What’s the risk of dying from a fast-spreading COVID-19 variant?
What’s the risk of dying from a fast-spreading COVID-19 variant? – Nature Original study: Increased hazard of death in community-tested cases of SARS-CoV-2 Variant of Concern 202012/01 – medRxiv
The post What’s the risk of dying from a fast-spreading COVID-19 variant? appeared first on Links Medicus.
The good and the (potentially) bad: What scientists know about variants and Covid-19 vaccines
The good and the (potentially) bad: What scientists know about variants and Covid-19 vaccines – STAT See also: What Will it Take to Make Covid-19 Vaccines Variant-Proof? – Wired AND What’s Going On With All These Coronavirus Variants? An Illustrated Guide – NPR AND Video: Coronavirus Variants – What They Mean – JAMA
The post The good and the (potentially) bad: What scientists know about variants and Covid-19 vaccines appeared first on Links Medicus.
[Press release – not published yet] Covid-19: Oxford vaccine offers less protection against South Africa variant
Oxford Covid-19 vaccine trial results – University of the Witwatersrand Commentaries: Covid: Oxford jab offers less S Africa variant protection – BBC AND Expert reaction to news reports that the Oxford/AZ vaccine gives limited protection against mild disease caused by the South African variant of SARS-CoV-2 – Science Media Centre AND Oxford/AstraZeneca COVID shot less […]
The post [Press release – not published yet] Covid-19: Oxford vaccine offers less protection against South Africa variant appeared first on Links Medicus.
[Press release – not published yet] Sinovac Announces Phase III Results of Its COVID-19 Vaccine
Sinovac Announces Phase III Results of Its COVID-19 Vaccine Commentaries: Expert reaction to announcement of results of phase III of Sinovac vaccine in China – Science Media Centre AND Sinovac says COVID-19 vaccine effective in preventing hospitalization, death – Reuters Commentary on Twitter (thread – click for more) Sinovac's CoronaVac's phase 3 trial results: […]
The post [Press release – not published yet] Sinovac Announces Phase III Results of Its COVID-19 Vaccine appeared first on Links Medicus.
Case report: SARS-CoV-2 evolution in immunocompromised patient treated with convalescent plasma
SARS-CoV-2 evolution during treatment of chronic infection – Nature Commentary on Twitter Just published @nature: The evolution of #SARSCoV2 in an immunocompromised patient, over > 100 days, that markedly accelerated once treated w/ convalescent plasma, with mutations that altered the response to neutralizing antibodies, by @GuptaR_lab https://t.co/SI4QL6BRXe pic.twitter.com/wqI1C2EYjQ — Eric Topol (@EricTopol) February 5, […]
The post Case report: SARS-CoV-2 evolution in immunocompromised patient treated with convalescent plasma appeared first on Links Medicus.
NIH Treatment Guideline Update: “there are insufficient data to recommend either for or against the use of tocilizumab or sarilumab for the treatment of COVID-19”
The COVID-19 Treatment Guidelines Panel’s Statement on the Use of Tocilizumab (and Other Interleukin-6 Inhibitors) for the Treatment of COVID-19 – National Institutes of Health
The post NIH Treatment Guideline Update: “there are insufficient data to recommend either for or against the use of tocilizumab or sarilumab for the treatment of COVID-19” appeared first on Links Medicus.
Systematic review: Telerehabilitation for chronic respiratory disease
Telerehabilitation for chronic respiratory disease – Cochrane Library Summary: How does using technology to deliver pulmonary rehabilitation (PR) compare to centre-based PR, or no PR in people with chronic lung disease? – Cochrane Library
The post Systematic review: Telerehabilitation for chronic respiratory disease appeared first on Links Medicus.
Prevalence and trends in tobacco use among adolescents aged 13–15 years in 143 countries, 1999–2018: findings from the Global Youth Tobacco Surveys
Prevalence and trends in tobacco use among adolescents aged 13–15 years in 143 countries, 1999–2018: findings from the Global Youth Tobacco Surveys – The Lancet Child & Adolescent Health (link to abstract – $ for full-text) Commentary on Twitter NEW—Global Youth Tobacco Surveys data from 13–15-year-olds in 140 countries, suggests 40% of countries show […]
The post Prevalence and trends in tobacco use among adolescents aged 13–15 years in 143 countries, 1999–2018: findings from the Global Youth Tobacco Surveys appeared first on Links Medicus.
Systematic review: No evidence that patients with asthma are at increased risk of COVID-19 diagnosis, hospitalization or death
Asthma in Adult Patients with COVID-19: Prevalence and Risk of Severe Disease – American Journal of Respiratory and Critical Care Medicine Commentary: Asthma Patients Get Reassurance on COVID-19 — Research review finds no firm evidence of increased risk for severe illness, death – MedPage Today
The post Systematic review: No evidence that patients with asthma are at increased risk of COVID-19 diagnosis, hospitalization or death appeared first on Links Medicus.
[Preprint] Meta-analysis: More than 50 Long-term effects of COVID-19
More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis – medRxiv Commentary: 80% of COVID-19 Patients May Have Lingering Symptoms, Signs — More than 50 effects persisted after acute infection, meta-analysis shows – MedPage Today (free registration required)
The post [Preprint] Meta-analysis: More than 50 Long-term effects of COVID-19 appeared first on Links Medicus.